Old Web
English
Sign In
Acemap
>
authorDetail
>
Peter C. Riebling
Peter C. Riebling
ROR1
Cancer research
safety profile
clinical efficacy
Diffuse large B-cell lymphoma
1
Papers
8
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
VLS-101, a ROR1-Targeting Antibody-Drug Conjugate, Demonstrates a Predictable Safety Profile and Clinical Efficacy in Patients with Heavily Pretreated Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma
2020
Blood
Michael Wang
Jacqueline C. Barrientos
Richard R. Furman
Matthew Mei
Paul M. Barr
Michael Y. Choi
Sven de Vos
Avyakta Kallam
Krish Patel
Simon Rule
Kate Flanders
Katti Jessen
Peter C. Riebling
Patricia Graham
Lydia B King
Elizabeth M. Schmidt
Brian Lannutti
David Michael Johnson
Langdon L. Miller
Stephen E. Spurgeon
Show All
Source
Cite
Save
Citations (8)
1